Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Biomind Labs Inc.

News headline image
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
From Biomind Labs Inc.
Via Business Wire
Tickers BMNDF
News headline image
Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression
From Biomind Labs Inc.
Via Business Wire
News headline image
Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form
From Biomind Labs Inc.
Via Business Wire
News headline image
Biomind Labs to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression
From Biomind Labs Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.